Prison and HIV-1 Infection among Drug Injectors

World Health Organization: Drug Injecting and HIV Infection: Global Dimensions and Local Responses

Volumn , Issue , 2003, Pages 168-182

  Abeni, Damiano ^a   Perucci, Carlo A ^b   Dolan, Kate ^c   Sangalli, Massimo ^b  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b Lazio Regional Health Service   (Italy)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0008518167     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203214015-17     Document Type: Chapter

References (59)

1. BIRD, A.G. and GORE, S.M. (1994) ‘Inside methodology: HIV surveillance in prisons’, AIDS, 8, pp. 1345-6.
2. BIRD, A.G., GORE, S.M., JOLLIFFE, D.W. and BURNS, S.M. (1992) ‘Anonymous HIV surveillance in Saughton Prison, Edinburgh’, AIDS, 6, pp. 725-33.
3. BREWER, T.F., VLAHOV, D., TAYLOR, E., HALL, D., MUNOZ, A. and POLK, F. (1988) ‘Transmission of HIV-1 within a statewide prison system’, AIDS, 2, pp. 363-7.
4. CARVELL, A.L.M. and HART, G.J. (1990) ‘Risk behaviours for HIV infection among drug users in prisons’, British Medical Journal, 300, pp. 1383-4.
5. CASTRO, K., SHANSKY, R., SCARDINO, V., NARKUNAS, J. and HAMMETT, T. (1991) ‘HIV transmission in correctional facilities’, 16-21 June, p. 314. Paper presented at the VIIth International Conference on AIDS, Florence.
6. CENTERS FOR DISEASE CONTROL (1986) ‘Acquired immunodeficiency syndrome in correctional facilities: A report of the National Institute of Justice and the American Correctional Association’, Morbidity and Mortality Weekly Report, 35, pp. 195-9.
7. CENTERS FOR DISEASE CONTROL (1989) ‘AIDS and human immunodeficiency virus infection in the United States: 1988 update’, Morbidity and Mortality Weekly Report, 38, (S-4), pp. 1-38.
8. CENTERS FOR DISEASE CONTROL (1992) ‘HIV prevention in the U.S. correctional system, 1991', Morbidity and Mortality Weekly Report, 41, pp. 389-97.
9. CHOOPANYA, K. (1989) AIDS and Drug Addicts in Thailand, Bangkok:Bangkok Metropolitan Authority Department of Health.
10. CHRISTIE, B. (1993) ‘HIV outbreak investigated in Scottish jail’, British Medical Journal, 307, pp. 151-2.
11. CLAVEL, T., LECOURT, J.F., DEMAIN, A., ROUSSEAU, I. and THOMAS, P. (1992) ‘HIV seroprevalence and risk factors among female inmates in a French prison’, Journal of the Acquired Immune Deficiency Syndromes, 5, pp. 428-30.
12. CROFTS, N., WEBB-PULLMAN, J. and DOLAN, K. (1996) An analysis of trends over time in social and behavioural factors related to the transmission of HIV among IDUs and prison inmates, Canberra: AGPS.
13. DECKER, M.D., VAUGHN, W.K., BRODIE, J.S., HUTCHESON, R.H. and SCHAFFNER, W. (1984) ‘Seroepidemiology of hepatitis B in Tennessee prisoners’, Journal of Infectious Diseases, 150, pp. 450-59.
14. DECKER, M.D., VAUGHN, W.K., BRODIE, J.S., HUTCHESON, R.H. and SCHAFFNER, W. (1985) ‘Incidence of hepatitis B in Tennessee prisoners’, Journalof Infectious Diseases, 152, pp. 214-17.
15. DOLAN, K. and WODAK, A. (1996) ‘An international review of methadone provision in prisons’, Addictions Research, 4 (1), pp. 85-97.
16. DOLAN, K., HALL, W. and WODAK, A. (1994) ‘Bleach availability and risk behaviour in prison in New South Wales’, Technical Report, 22, Sydney:National Drug and Alcohol Research Centre.
17. DOLAN, K.A., TURNBULL, P.J. and STIMSON, G.V. (1991) ‘HIV prevalence and risk behaviour of 452 prisoners in England’, Abstract W.C. 3321, VII International Conference on AIDS. Florence.
18. DOLAN, K., WODAK, A. and PENNY, R. (1995) ‘AIDS behind bars: Preventing HIV spread among incarcerated drug injectors’, AIDS, 9, pp. 825-32.
19. DOLAN K., SHEARER, J., HALL, W. and WODAK, A. (1995) ‘Bleach easier to obtain but inmates still risk infection in New South Wales prisons’, Technical Report, Sydney: National Drug and Alcohol Research Centre.
20. DYE, S. and ISAACS, C. (1991) ‘Intravenous drug misuse among prison inmates:Implications for spread of HIV’, British Medical Journal, 302, p. 1506.
21. FEDERAL OFFICE OF PUBLIC HEALTH (1993) ‘HIV prevention in Switzerland: Targets, strategies, interventions’, Bern: National AIDS Commission.
22. GAUGHWIN, M.D., DOUGLAS, R.M. and WODAK, A.D. (1991) ‘Behind bars-risk behaviours for HIV transmission in prisons, a review’, in NORBERRY, J., GERULL, S.A. and GAUGHWIN, M.D. (Eds) HIV/AIDS and Prisons Conference Proceedings.Canberra: Australian Institute of Criminology.
23. GAUGHWIN, M.D., DOUGLAS, R.M., LIEW, C., DAVIES, L., MYLVAGANAM, A., TREFFKE, H., EDWARDS, J. and ALI, R. (1991) ‘HIV prevalence and risk behaviours for HIV transmission in South Australian prisons’, AIDS, 5, pp. 845-51.
24. GELLERT, G.A., MAXWELL, R.M., HIGGINS, K.V., PENDERGAST, T. and WILKER, N. (1993) ‘HIV infection in the Women’s jail, Orange County, California, 1985 through 1991', American Journal of Public Health, 83, pp. 1454-6.
25. GORE, S.M. and BIRD, A.G. (1993) ‘No escape: HIV transmission in jail’, British Medical Journal, 307, pp. 147-8.
26. GORE, S.M., BIRD, A.G. and Ross, A.J. (1995) ‘Prison rites: Starting to inject inside’, British Medical Journal, 311, pp. 1135-6.
27. GORE, S.M., BIRD, A.G., BURNS, S.M., GOLDBERG, D.J., Ross, A.J. and MACGREGOR, J. (1995) ‘Drug injection and HIV prevalence in inmates of Glenochil prison’, British Medical Journal, 310, pp. 293-6.
28. GRANADOS, A., MIRANDA, M.J. and MARTIN, L. (1990) ‘HIV seropositivity in Spanish prisons’. Abstract Th.D.116, VI International Conference on AIDS, San Francisco.
29. HAMMETT, T. (1988) ‘AIDS in correctional facilities: Issues and options’, Washington, DC: US Department of Justice, National Institute of Justice.
30. HANKINS, C.A., GENDRON, S., HANDLEY, M.A., RICHARD, C., LAI TUNG, M.T. and O’SHAUGHNESSY, M. (1994) ‘HIV infection among women in prison: An assessment of risk factors using a nonnominal methodology’, American Journal of Public Health, 84, pp. 1637-40.
31. HARDING, T.W. (1987) ‘AIDS in prison’, The Lancet, ii, pp. 1260-3.
32. HORSBURGH, C.R., JARVIS, J.Q., MCARTHUR, T., IGNACIO, T. and STOCK, P. (1990) ‘Seroconversion to human immunodeficiency virus in prison inmates’, American Journal of Public Health, 80, pp. 209-10.
33. HOXIE, N.J., VERGERONT, J.M., FRISBY, H.R., PFISTER, J.R., GOLUBJATNIKOV, R. and DAVJS, J.P. (1990) ‘HIV seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin’, American Journal of Public Health, 80, pp. 1129-31.
34. HULL, H.F., LYONS, L.H., MANN, J.M., HADLER, S.C., STEECE, R. and SKEELS, M.R. (1985) ‘Incidence of Hepatitis B in the penitentiary of New Mexico’, American Journal of Public Health, 75, pp. 1213-14.
35. KELLEY, P.W., REDFIELD, R.R., WARD, D.L., BURKE, D.S. and MILLER, R.N. (1986) ‘Prevalence and incidence of HTLV-III infection in a prison’, Journal of the American Medical Association, 256, pp. 2198-9.
36. KENNEDY, D.H., NAIR, G., ELLIOTT, L. and DITTON, J. (1991) ‘Drug misuse and sharing of needles in Scottish prisons’, British Medical Journal, 302, p. 1507.
37. MADEN, A., SWINTON, M. and GUNN, J. (1991) ‘Drug dependence in prisoners’, British Medical Journal, 302, p. 880.
38. MUTTER, R.C., GRIMES, R.M. and LABARTHE, D. (1994) ‘Evidence of intraprison spread of HIV infection’, Archives of Internal Medicine, 154, pp. 793-5.
39. NELLES, J. and HARDING, T. (1995) ‘Preventing HIV transmission in prison:A tale of medical disobedience and Swiss pragmatism’, The Lancet, 346, pp. 1507-8.
40. PONT, J., STRUTZ, H., KAHL, W. and SALZNER, G. (1994) ‘HIV epidemiology and risk behavior promoting HIV transmission in Austrian prisons’, European Journal of Epidemiology, 10, pp. 285-9.
41. POWER, K.G., MARKOVA, I., ROWLANDS, A., MCKEE, K.J., ANSLOW, P.J. and KILFEDDER, C. (1991) ‘Sexual behaviour in Scottish prisons’, British Medical Journal, 302, pp. 1507-8.
42. PRESIDENZA DEL CONSIGLIO DEI MINISTRI-DIPARTIMENTO PER GLI AFFARI SOCIALI, (1993) ‘Relazione sui dati relativi allo stato delle tossicodipendenze in Italia, sulle strategie adottate e sugli obiettivi raggiunti nel 1992', Roma.
43. RUTTER, S., DOLAN, K., WODAK, A., HALL, W., MAHER, L. and DIXON, D. (1995) ‘Is syringe exchange feasible in a prison setting? An exploratory study of the issues’, Technical Report, Sydney: National Drug and Alcohol Research Centre.
44. SALIVE, M.E., SMITH, G.S. and DOLAN, K.A. (1990) ‘Death in prison:Changing mortality patterns among male prisoners in Maryland 1979-87', American Journal of Public Health, 80, pp. 1479-80.
45. SCOTTISH AFFAIRS COMMITTEE (1994) ‘Drug Abuse in Scotland, Report’, London: HMSO.
46. SHAPSHANK, P., MCCOY, C.B., RIVERS, J.E., CHITWOOD, D.D., MASH, D.C., WEATHERBY, N.L., INCIARDI, J.A., SHAH, S.M. and BROWN, B.S. (1993) ‘Inactivation of human immunodeficiency virus-1 at short time intervals using undiluted bleach’, Journal of the Acquired Immune Deficiency Syndromes, 6, pp. 218-19.
47. TAYLOR, A., GOLDBERG, D., EMSLIE, J., WRENCH, J., GRUER, L., CAMERSON, S., BLACK, J., DAVIS, B., MCGREGOR, J., FOLLETT, E., HARVEY, J., BASSON, J. and MCGAVIGAN, J. (1995) ‘Outbreak of HIV infection in a Scottish prison’, British Medical Journal, 310, pp. 289-92.
48. TURNBULL, P.J. and STIMSON, G.V. (1993) ‘Prisons: Heterosexuals in a risk environment’, in SHERR (Ed.), AIDS and the heterosexual population, Reading: Harwood.
49. TURNBULL, P.J., DOLAN, K.A. and STIMSON, G.V. (1991) Prisons, HIV and AIDS: Risk and Experiences in Custodial Care, Horsham: Avert.
50. TURNBULL, P.J., STIMSON, G.V. and DOLAN, K.A. (1992) ‘Prevalence of HIV infection among ex-prisoners in England’, British Medical Journal, 304, pp. 90-1.
51. TURNBULL, P.J., STIMSON, G.V. and STILLWELL, G. (1994) Drug use in prison, Horsham: Avert.
52. VLAHOV, D., BREWER, F., MUÑOZ, A., HALL, D., TAYLOR, E. and POLK, B.F. (1989) ‘Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987', Journal of the Acquired Immune Deficiency Syndromes, 2, pp. 283-90.
53. VLAHOV, D., MUÑOZ, A., BREWER, F., TAYLOR, E., CANNER, C. and POLK, B.F. (1990) ‘Seasonal and annual variation of anitbody to HIV-1 among male inmates entering Maryland prisons: Update’, AIDS, 4, pp. 345-50.
54. VLAHOV, D., BREWER, T.F., CASTRO, K.G., NARKUNAS, J.P., SALIVE, M.E., ULLRICH, J. and MUÑOZ, A. (1991) ‘Prevalence of antibody to HIV-1 among entrants to US correctional facilities’, Journal of the American Medical Association, 265, pp. 1129-32.
55. WEISFUSE, I.B., GREENBERG, B., BACK, S.D., MAKKI, H.A., THOMAS, P., ROONEY, W.C. and RAUTENBERG, E.L. (1991) ‘HIV-1 infection among New York city inmates’, AIDS, 5, pp. 1133-8.
56. WHO (1987) World Health Organization, ‘WHO consultation on prevention and control of AIDS in prisons’, The Lancet, ii, pp. 1263-4.
57. WHO (1993) World Health Organization, Global Programme on AIDS, ‘WHO guidelines on HIV infection and AIDS in prisons’, Geneva: World Health Organization.
58. WITHUM, D.G., GÜEREÑA-BURGUEÑO, F., GWINN, M., STAN LEHMAN, J. and PETERSEN, L.R. (1993) ‘High HIV prevalence among female and male prisoners in the United States (1989-1992): Implications for prevention and treatment strategies’, Abstract PO-C21-3115, IX International Conference on AIDS, Berlin.
59. WORMSER, G.P., KRUPP, L.B., HANRAHAN, J.P., GAVIS, G., SPIRA, T.J. and CUNNINGHAMRUNDLES, S. (1983) ‘Acquired immunodeficiency syndrome in male prisoners’, Annals of Internal Medicine, 98, pp. 297-303.